Lessons learned from past HIV vaccine trials and recent technological as well as scientific advancements in the fields of HIV biology, immunology, and vaccinology allow us to conceive of a forthcoming effective HIV vaccine.

Public health officials continue to denounce the ban on federal funding for syringe exchange programs as a policy that is counter to what science tells us is a sensible and cost-effective public health strategy.